[임경민] Are recently evaluated drugs more likely to receive positive reimbursement recommendations in South Korea? 11-year experience of the Korean positive list system


제목	[임경민] Are recently evaluated drugs more likely to receive positive reimbursement recommendations in South Korea? 11-year experience of the Korean positive list system2020-06-10 13:30
카테고리	2020
LINK : Clinical Therapeutics, Volume 42, ISSUE 7, P1222-1233 제 목 : Are recently evaluated drugs more likely to receive positive reimbursement recommendations in South Korea? 11-year experience of the Korean positive list system 저 자 : Ji Ryoun Gong, Donghwan Lee, Kyung-Min Lim, SeungJin Bae* 저널명 : Clinical Therapeutics (IF=3.119) 게재년월 : 2020년 5월 DOI : 10.1016/j.clinthera.2020.05.006 ※ Impact Factor(IF)는 2019 기준임

이전	[임경민] Antithrombotic Effects of Paeoniflorin from Paeonia suffruticosa by Selective Inhibition on Shear Stress-Induced Platelet Aggregation
-	[임경민] Are recently evaluated drugs more likely to receive positive reimbursement recommendations in South Korea? 11-year experience of the Korean positive list system
다음	[임경민] Arsenic induces platelet shape change through altering focal adhesion kinase-mediated actin dynamics, contributing to increased platelet reactivity

FCC

EWHA WOMANS UNIVERSITY COLLEGE OF PHARMACY FIBROSIS CONTROL CENTER